Key Bio/Pharma Assets at the PTAB

Through more focused strategy, patent owners have ensured that Patent Trial and Appeal Board (PTAB) proceedings are not overwhelmingly fatal to Orange and Purple Book patents. In fact, patent invalidity rates at the PTAB now rival those in district court litigation.

Ropes and Gray’s IP Litigation (Life Sciences) Chair